EGFR-IN-170
EGFR-IN-170 (Compound 5c) is an EGFR inhibitor with an IC50 of 5.17 μM. It induces apoptosis by inhibiting Bcl2 and activating Bax expression, notably increasing the Bax/Bcl2 ratio. EGFR-IN-170 exhibits potent anticancer activity and is capable of inhibiting the growth of resistant lung cancer cells.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog